COLORADO SPRINGS, Colo.,
Aug. 20, 2013 /PRNewswire/
-- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company
specializing in cannabinoid formulation-based health and wellness
solutions, entered into a multi-year, strategic growth agreement
with Medicine Dispensing Systems, a wholly owned subsidiary of
Medbox, Inc., a publicly traded company, to provide its scientific
and clinical expertise for ten medical cannabis dispensaries and
cultivation facilities in the states of Arizona, California, Illinois, Massachusetts, Nevada, and Washington State.
This milestone agreement provides X-Change Corp with the real
opportunity to develop premiere branding and to introduce the
Company's proprietary cannabinoid-based products and formulations
within each state's regulatory framework.
Dr. Dorothy Bray, President of
X-Change Corporation, stated, "This agreement will allow X-Change
Corp to introduce much needed scientific research and improved
clinical management into dispensaries to benefit patients. Medbox
represents the gold standard in pharmaceutical and alternative
medication dispensing and will help us to employ best-in-industry
practices and improve our focus on clinical management aspects,
accompanied by the scientific documentation and research to monitor
clinical progress of patients. Our novel approach position
will set us even further apart from our competitors."
Under the agreement, as a part of each dispensary build-out,
X-Change Corp will brand the operations with a new image and employ
a market-exclusive use of the patented Medbox system. Medbox
technology and software allows for biometric patient and employee
identification, internal documentation and tracking of dispensing
services for internal accounting and compliance purposes, and
secure inventory management and control. In its efforts to
enter the legal medical cannabis dispensary space, X-Change Corp
expects to announce the signing of a significant dispensary
management agreement in the very near term.
About The X-Change Corporation
The X-Change Corporation is currently developing new natural
cannabinoid containing products based on innovative formulations to
utilize the unique and potent benefits of the cannabis and hemp
plants. Medicinal properties of cannabis and hemp have been known
and applied for thousands of years. With the aid of scientific
research, The X-Change Corporation is translating such knowledge
into development of effective cannabinoid formulation-based health
and wellness solutions as well as cosmeceutical, nutraceutical, and
food brands throughout the world. The Company's health and
wellness, nutritional, and cosmetics lines will address personal
needs and will evolve with the introduction of new formulations and
products, advancing the Company within the expanding
multibillion-dollar global market.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. X-Change Corp. does not undertake any duty nor does it
intend to update the results of these forward-looking
statements.
X-Change Corp.
President
Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595
Investment Inquiries
Robert Kane
CFO, Sr Vp of Business Development
rkane@xchangecorp.com
+1.561.420.4824
SOURCE The X-Change Corporation